Pipeline coverage: how much pipeline you actually need
Pipeline coverage compares open deals with the target. How much you need is one divided by your own win rate, worked through in a table. Then two traps: a healthy average hiding a thin segment, and deals that close after the quarter ends.
Pipeline velocity: the number that tells you when revenue arrives
Coverage says how much pipeline you have, win rate how often you close, deal size how big. None says when the money arrives. Pipeline velocity does, in rupees per day, and its arithmetic shows which of four levers is worth pulling.
Should your product sell itself, or do you need a sales team?
Many founders copy a go-to-market motion and inherit its costs. Product-led, sales-led and hybrid each trade spending against the time it takes to earn it back. How to choose for your product and buyer, and the signs it is time to add a second motion.
The one-page monthly review for doctor-founders
A doctor-founder has forty minutes on a Sunday for the month's numbers. Six blocks on one page, from service lines and loaded margin to cash, receivables and capital projects, turn that time into decisions.
Why Amplifon left India, and what Hearzap sees in the same clinics
Amplifon sold about 115 Indian clinics to Hyderabad's Hearzap in August 2026. The same clinics that weighed on a global group can pay for a local owner. What clinic chains can learn, and the number that will show whether the deal worked.
Ten sales pipeline metrics, four questions
A pipeline report can show four times the target and the quarter can still miss. Ten metrics, grouped under four plain questions, show which part of the pipeline is failing and what to fix first.
The hospital's own vitals: six numbers, one page, once a week
Occupancy, length of stay, OPD to IPD conversion, readmissions, ARPOB and collections, side by side each week. What each number answers, what movement should worry you, and why your own trend beats any published range.
Your hospital's hidden number: break-even admissions
Profit in a hospital does not grow in step with patients. Below break-even every empty bed costs money; above it, most of each extra admission's margin is profit. A worked example in admissions, not occupancy.
Why department P&Ls mislead a hospital, and what to cost instead
A knee replacement can look healthy on the orthopaedics report until the two ICU nights it needed are counted. Why to cost the whole stay, from admission to discharge, and how to share it when several specialists treat one patient.
Why comparing your ARPOB with the big chains misleads you
ARPOB looks like a price, yet nobody is ever charged it. It blends case mix, payer mix, location and length of stay, and only one of those is yours to move this year.
The HR checklist for startups after a seed or Series A raise
Just raised? A 90-day HR checklist for seed and Series A startups: contracts, compliance, policies, insurance and onboarding, in the order that matters.
Consultant, employee or intern? The legal differences in India
A consultant agreement does not make someone a consultant. How Indian law tells employees, consultants and interns apart, and what the wrong label costs a startup.
Offer letter vs appointment letter: what each one does in India
Many startups send one document and call it an offer letter. What each letter is for, what the labour codes now require, and the mistakes that surface later.
Form 3CEB: the transfer pricing report your Indian subsidiary files every year
Any dealing between an Indian subsidiary and its US parent brings a Form 3CEB. Who files, the 31 October 2026 due date, the flows that get missed, the penalties, and the move to Form 48.
Form 5471 for US companies with an Indian subsidiary
A US company with an Indian subsidiary files Form 5471 every year. Which category applies, what the form needs from Indian books, the calendar-year problem, and what a missed form costs.
When should a startup hire its first HR person?
Most startups don't need a full-time HR hire until about 50 people, but they need HR judgement much earlier. Here is how to tell when, and what to do until then.
US–India transfer pricing: how to price the work your India team does
If your India subsidiary bills its US parent, the price on those invoices decides how much profit each country taxes. How to set it, document it in both countries and true it up.
Intercompany services agreement: a clause-by-clause outline for India and the US
The clauses an Indian subsidiary's services agreement with its US parent needs, with the tax, GST and FEMA points each one has to carry.
ABC Analysis: Classify on Two Dimensions, Not One
Ranking items by value and cutting the tail looks rigorous and quietly destroys value. Two fixes make the difference: classify on two dimensions, and check the basket before deleting anything.
Industry Lifecycle: Stage Is per Segment, Not per Industry
The same product is often mature in the metros and still growing two hundred kilometres away. An industry-level lifecycle verdict hides that, and it is usually the most actionable thing available.
TAM, SAM and SOM: The Assumptions Are the Deliverable
A market size is entirely a function of its assumptions, which makes the assumptions the real output. Most sizing work fails because it starts from a published industry figure and works down.
The Ansoff Matrix Names the Boxes, Not the Choice
Ansoff is a sorting device, not a decision. Most companies reach for new markets or new products while the cheapest growth is still sitting unexhausted in the first quadrant.
PESTEL Analysis: The Filtering Is the Work
A PESTEL that names eighteen undifferentiated factors is a school exercise. The version that changes a decision states four things about every factor, then deletes most of them.
Porter's Five Forces: What It Explains, and What It Does Not
Most Five Forces analysis produces five ratings and no decisions. The fix is to name the mechanism behind each force, and to know the one question the framework cannot answer about your own company.
Costing in Pharma: Batch, Market and the Cost of Being Allowed to Sell
Same product, same plant, four markets, four very different costs, because the cost of permission differs. How to build cost per batch, then cost per market, and apportion quality and regulatory cost on what consumes it.
Costing a D2C or Ecommerce Business: The Product, the Order and the Margin Stack
Most D2C brands cost the product and stop. The order is a second cost object, carrying shipping, platform fees, warehousing, service, returns and refused deliveries, and it only shows up once shared costs are apportioned on what drives them.
Costing a Hardware, Robotics or Semiconductor Business
In hardware, the two costs that decide the price are not yet facts: development spend recovered over volume you have not sold, and a yield that is still improving. How to cost both, and the provisions that get left out.
Costing a SaaS Business: Cost per Account-Month and How to Apportion Engineering
Seats are what you charge for. Accounts are what you serve, and cost follows service. How to cost each account-month, where engineering belongs, and what the result says about your plans.
Costing an IT Services Firm: Cost per Billable Hour, Pyramid Mix and Account Margin
An IT services firm buys people by the month and sells them by the hour. Cost per billable hour by grade, and the pyramid mix each project is actually delivered on, decide whether a quote makes money.
Costing a Hospital or Diagnostic Chain: Procedure, Bed-Day and Test
Two cases can earn the same package rate while one takes forty minutes of theatre time and the other four hours. Hospital costing that charges theatre by the minute and nursing by acuity shows which one pays.
Planned vs Actual: What the Variance Is Telling You
A project estimated at 340 hours delivered in 470. That gap has at least four causes with four different owners, and a single number names none of them. How to set the plan figure, read variances in pairs and start with just three items.
Build or Buy, Properly Costed
A ₹24.7 lakh build against a ₹14 lakh licence looks like an easy call to buy. Ask which costs actually leave if you don't build, and the answer is ₹1.2 lakh. The real question is what the released capacity is worth.
What One Unit Actually Costs You
A senior engineer on ₹18 lakh a year looks like ₹900 an hour. Loaded, and divided by the hours actually billed, the same person costs ₹2,350 an hour. Every business has its own version of that gap.
Why Your Unit Cost Moves With Volume, and Why Cost-Plus Eats Itself
A services firm's cost per billable hour rises 40% in a soft quarter without a rupee of spending moving. Cost-plus then asks for a 40% price rise into a weak market, and the loop closes. Absorption is for reporting; contribution is for decisions.
Cost Apportionment: The Allocation That Decides Everything After It
How you split the costs nobody can trace decides every margin, floor and investment call after it. One hospital's revenue split was hiding a department that used far more than it paid for.
Cost to Serve: Why Two Identical Customers Earn You Different Money
Two accounts paying ₹18 lakh a year on the same plan can earn very different money once you count what each one consumes. How to cost each customer, rank them, and act on the ones that lose money.
The Week Software Started Charging for Results
Two rounds were 80% of the week. The more useful signal was underneath: four of the five AI companies funded sell work done rather than software used, and Ema says it charges per completed task.
Slow money on a machine, fast money on a round
A SIDBI machinery loan and a venture debt term sheet are both debt, and almost nothing else about them is alike, starting with who decides to lend.
A grant takes no shares, and it is not free
Every grant scheme in our register leaves your cap table alone. Each one bills you somewhere else, on a schedule you do not set and cannot renegotiate later.
The shareholder you did not pitch
A grant leaves your share register alone. The three equity schemes in our register do not, and one of them puts a name on it that nobody in your company has met.
SMILE, and the soft loan that pays part of your own contribution
Every lender asks what you are putting in before they tell you what they will lend. SIDBI runs a scheme that will fund a slice of your side of that answer.
Stand-Up India: three percentages that only make sense together
A composite bank loan of INR 10 lakh to INR 1 crore for SC, ST and women entrepreneurs, closed since 31 March 2025. Its rules are the best guide to the successor announced in Budget 2025-26.
A crore of seed equity for agritech, and the clauses nobody prints
Up to INR 1 crore of seed equity for an agritech startup, through the agribusiness incubator at ICAR-NAARM. Most of what you read about it is a summary, not the test.
The Startup India Seed Fund is closed. What now?
The scheme at the top of every list of Indian startup funding has not accepted an application since May 2026, and most of those lists have not been updated.
The grant that funds a person, not a company
It funds a person rather than a company, and it stays a grant right up until the day you abandon the project.
The defence seed fund you cannot apply to cold
SIDBI puts INR 10 lakh to INR 1.5 crore of equity into defence startups through SINE at IIT Bombay. The interesting part is who is allowed to ask.
MeitY will match the round you have already banked
Almost every government scheme asks you to argue for money. This one asks you to prove that somebody else has already given you some.
Money to build the thing: how the PRAYAS prototype grant works
The scheme is central and the money is the Department of Science and Technology's. Almost every decision that affects you is made by a host centre you have to pick first.
CGSS: how a startup borrows with nothing to pledge
Founders read the words credit guarantee and hear funding. The scheme pays your lender, never you, and seeing that clearly is what makes it usable.
The Design Linked Incentive, and the two benefits founders mix up
One scheme, two incentives, two completely different tests. Chip teams routinely pitch us the ceiling from one of them and the eligibility of the other.
Seven ways a government funding application gets turned down
Almost every rejection we see is a test the founder never knew was being applied. Five of the seven are settled before the committee reads a word.
DPIIT recognition: what it gets you, and what it does not
Recognition is a registration, not an award, and two of the benefits it is famous for do not work the way founders think they do.
Ten government schemes, and how to tell which one is for you
The hard part of government funding is not finding schemes. It is working out which of them you could actually win, and which are quietly closed.
What a government grant application actually asks you for
The form is the easy part. The documents that hold up a disbursement are corporate records, and you cannot produce those in the week you are asked for them.
When Revenue Multiples Apply, and When They Don't
A revenue multiple is an earnings multiple in disguise. What actually decides whether one applies, at what scale it starts to mean anything, and which revenue line it attaches to.
MCA Data Is a Good Starting Point, and Only a Starting Point
Every Indian company files, and the accounts are audited. The work that turns twenty filings into comparable numbers is where a benchmark is won or quietly lost.
The Metrics That Actually Carry a Diagnosis
Forty ratios with a percentile beside each is a catalogue. A small number of measures carry the diagnosis, and this is which ones, and what a gap in each one means.
How to Benchmark a Business, and Why Most Benchmarking Fails
Benchmarking works when it is attached to a decision. The six domains worth measuring, the seven economic engines that decide which metrics apply, and what makes a peer set hold up.
The five contract numbers that belong in your board pack
Five numbers your contracts already hold, plus the reconciliation your auditor wants: how much of reported revenue rests on a signed document.
Your ESOP pool may not legally exist
Most companies below Series B can produce one of the three documents an option pool needs. Here is where the gap opens, and how to close it.
Flip and reverse flip: what actually breaks
Founders treat a holding-company move as paperwork. Five things break when they do, and four of them surface at the next diligence rather than now.
LLP compliance: what is different, and what it costs to ignore
People choose an LLP because it is cheaper to run and lighter to comply with. Both are true. The trouble is that founders hear "lighter" as "barely anything" and stop filing when the business goes quiet.
Investing outside India: ODI, LRS and the filings founders miss
Setting up a company abroad takes an afternoon. Holding it compliantly from India is the part that takes planning, and it's where founders get caught.
Liquidation preference and anti-dilution, with the maths
Founders negotiate valuation for weeks and these two clauses in about ten minutes. Valuation sets the headline; liquidation preference and anti-dilution decide what you actually receive.
Private limited, LLP or OPC: choosing and changing your structure
Most founders choose a structure on cost. The real cost of the decision is not the registration fee but what you pay to change your mind later, at a moment when you have no time.
The MSME owner's guide to getting paid, funded and sold
Customers pay late, credit is hard to get, and nobody has planned for the day the founder steps back. There are rules and records that help with all three, and most owners are not using them.
Contract governance without buying software
We ask a simple question in the first week of most engagements: how many contracts does the company have? Almost nobody knows.
Diligence readiness: what we check, and what we find
The business is usually fine and the numbers mostly hold up. What delays a deal is the record of the company: the documents, the filings, the registers, the contracts.
The commercial contract clauses that decide whether you get paid
Most founders treat a contract as the step before the work starts. It is actually where three things get settled: when you get paid, what a bad outcome costs you, and how much of your company you still own when someone looks closely.
Running a board that investors trust
Before you raise, your board is you and your co-founder. After you raise, it is a group of people with legal duties, a required rhythm and a record someone will eventually read.
The annual compliance map for a private limited company
Most founders know about two filings, the annual return and the financial statements. A private limited company owes many more, and several have nothing to do with the accounts.
From term sheet to money in the bank
Getting a term sheet feels like the finish line. It is the point where the real work starts, and the gap between signing and seeing the money is usually six to ten weeks.
ESOPs in India: what founders get wrong
Almost every startup we work with has an ESOP. Far fewer have one that would survive scrutiny, because the approval, the written scheme or the grant letters were never actually done.
Your cap table is probably wrong. Here's how to check.
Most founders can pull up a cap table in ten seconds. Proving it matches your register and your MCA filings is the harder, costlier part.
EPF Wage Ceiling Raised to ₹25,000: What It Means for Your Payroll
From 17 September 2026, provident fund coverage is compulsory up to ₹25,000 a month in wages, up from ₹15,000, the first change since 2014. What it costs an employer, who is newly covered, and what to settle before this month's payroll.
Funding Financial Inclusion in India
Financial inclusion is the deepest funder shelf in Indian impact investing, and the hardest place to qualify. The additionality question here isn't about your company. It's about which part of your book you're asking them to fund.
Funding Climate Transition in India
More concessional money points at climate than at anything else in this lane. It's also where the qualification test is hardest, because much of India's climate economy is already commercially funded.
Funding Food and Agriculture in India
Agriculture belongs to three impact themes at once, which gives it the widest funder shelf in this lane. It also has the hardest measurement problem: farmer income moves for a dozen reasons that have nothing to do with you.
India's Social Stock Exchange, Explained for Founders
About 176 non-profits had registered with the Social Stock Exchange by May 2026, and only 11 had actually listed. What changed, and who should bother.
Take Rate: How to Set It, Taper It and Defend It
A take rate you charge purely for access is the most vulnerable rate there is. How to design one your sellers can't route around.
Perceptyne: Building the Finance, Operations and Investor Backbone of a Robotics Startup
Perceptyne had three directors, big ambitions and no finance or operations infrastructure. SRF put a team inside its Hyderabad office and built it from the ground up.
Misochain: Pre-Audit Due Diligence for an Aerospace Components Maker
Misochain was building flight-critical aircraft parts faster than it was building its finance function. SRF was asked to find every gap an auditor would find, before the auditor did.
SecPod: How Retargeting the Sales Team Took a Cybersecurity SaaS Company to Positive EBITDA
SecPod's sales team was working hard and winning accounts, yet each new customer cost more than it would ever return. The fix was a targeting decision, and it took a single view of the numbers to see it.
Where the margin sits in robotics: components, robot makers and integrators
FANUC earns more than 21 cents of operating profit on every yen of sales. ABB Robotics earned about 12 and is being sold. The difference says more about business structure than about robots.
Solar Panel Manufacturing in India: Capacity, Policy and Who Makes Money
India now has more solar module factories than it can fill. The money and the risk have moved upstream, to cells and wafers, and to whoever can sell outside a closing US market.
Robots as a service: when renting a robot makes sense for an MSME
Renting a robot removes the upfront cheque, but it rarely makes automation cheaper. Whether it pays depends on shifts, service terms and who carries the risk if the part programme ends.
India's robot density: what the gap with Korea and China really tells you
India's robot density is a fraction of China's and a sliver of Korea's. The number is real, but it is often read as a to-do list when it is closer to a map of where automation pays.
Why India's robotics firms are integrators, and how they get out of the middle
Most Indian robotics companies are system integrators, which puts them in the least profitable layer of the chain. That is not a verdict. It is a starting position with three ways out.
Who actually buys industrial robots in India
In 2024, India's auto-component suppliers bought more robots than the vehicle makers they supply. That shift changes who a robotics vendor should be selling to, and how.
Robotics in manufacturing: the India report
India installs more industrial robots than all but five countries, yet runs one of the thinnest robot fleets per factory worker. This report maps who buys, who earns the margin, and where an Indian company can build something defensible.
Where India's food processing industry makes its money, and where it loses it
India loses about ₹1.53 lakh crore of food a year between the farm and the factory, while most of the profit is made several stages later. What that gap means for processors and investors.
What stops a ₹100 crore food processing business reaching ₹500 crore
Many regional food processors stall around ₹100 crore on commodity margins, one category and one channel. Three moves can change the trajectory, if they come in the right order and on real numbers.
Why a GI tag alone does not set the price of a saree
India has 103 handloom products registered under the GI Act, and most of them still sell next to copies using the same name. The tag is a starting right. Pricing power comes from what a business builds on it.
The SME IPO route in India, seen from the founder's side of the table
SEBI's 2025 rules made the SME IPO harder to use as a quick exit and better as a way for profitable small companies to raise growth capital. Here is how the route works, what it costs, and who should take it.
The handloom industry in India runs on credit, stock and records
Marketplaces have made handloom easier to find. They have not fixed who finances the yarn, who carries the stock, or who can prove where a saree came from, and that is where the value leaks.
What a blockchain can and cannot prove about handloom provenance
Blockchain traceability is arriving in Indian handloom through EU-funded projects and state hubs. The ledger is the easy part. The record at the loom decides whether any of it is worth paying for.
Employer of record in India: how it works, what it costs, when to exit
An employer of record lets a foreign company employ people in India without an Indian entity. It is fast and clean for a small team and expensive for a large one. This report sets out how it works, what it costs, and when to leave.
The staffing industry in India: size, economics and who wins
India's staffing and recruitment market is forecast to nearly triple by 2030, but most of that revenue passes straight through to wages. This report maps where the margin actually sits, who holds it, and what founders and investors should do about it.
What the GCC boom in India means for staffing firms
India's global capability centres employ 2.36 million people. For staffing firms the opportunity is less about supplying heads and more about moving up to hiring, set-up and running the centre.
India's talent economy is a portfolio, not a single bet
India will supply roughly a quarter of the world's new workers over the next decade. The businesses that hire, pay and manage them are not one investment theme but seven, with very different risk.
MES, ERP, QMS and IoT: What Root Cause Analysis Needs to Connect To
A root cause investigation is only as good as the records it can read. What each plant system contributes, which ones most Indian plants actually have, and the order to connect them without starting a two-year IT project.
The gig economy in India is turning into a staffing market
The Code on Social Security gave gig workers a legal identity and platforms a bill to pay. The worker records those platforms hold are now a staffing asset, but the consumer app is not automatically the one that profits.
How to read the numbers of staffing companies in India
A listed staffing company can grow revenue by a fifth and barely move its profit, and that is not a sign of distress. Here is what to read instead of the EBITDA margin.
What Downtime Really Costs an Indian Plant, and What to Measure First
Global downtime benchmarks, converted to rupees, produce numbers larger than most Indian plants' revenue. Here is how to calculate the real cost for your own lines, and which five numbers any analytics effort should produce first.
Why Indian Manufacturers Still Do Root Cause Analysis on Paper
Most Indian plants run root cause analysis in registers, WhatsApp threads and one senior technician's memory. The reasons are more interesting than cost, and the moment to switch is usually set by a customer or a regulator.
Where MSMEs Can Make Money in India's Gold Trade
Hallmarking, record prices and a 15% import duty are reshaping India's gold trade. Small jewellers and recyclers have real openings, but at ₹1.5 lakh per 10 grams the thing that decides who survives is cash.
India's Gold Refineries Have Capacity but Not Enough Gold
India built about 1,800 tonnes of formal gold refining capacity and then struggled to fill it. GIFT City's bullion exchange was meant to help, but its gold volumes stalled in FY26. What that means for refiners, jewellers and investors.
How Big Is the Root Cause Analysis Software Market, Really?
Published estimates for root cause analysis software disagree more than threefold, and the most quoted one cannot be traced. Here is what the defensible numbers say, and where the value in the category is actually priced.
Micron Sanand and the Gujarat Chip Cluster: What Is Running and What Is Not
Gujarat hosts half of India's approved chip units and all three that are shipping. A plant-by-plant status check on Micron Sanand and its neighbours, and what it means for suppliers.
Urban Mining in India: Where the Gold in E-Waste Really Is
India imports almost all its gold while about 2 million tonnes of electronics are thrown away each year. Urban mining is real, but the money for small firms is in collection and sorting, not in refining.
HBM Memory, Advanced Packaging and the Real Limits on AI Chips
The binding limits on AI hardware sit in memory stacks, packaging lines and one Dutch toolmaker. How each chokepoint works, how fast it is easing, and who gets paid while it lasts.
What the India Semiconductor Mission Has Bought, and What ISM 2.0 Changes
Five years in, the India Semiconductor Mission has twelve approved units and three in production. Its second phase shifts money toward the suppliers and IP the first phase could not reach.
Revenue Cycle Management in India: How the Industry Works and Where It Is Going
Revenue cycle management is the chain of work that turns a hospital visit into cash. India runs much of it for American hospitals and is only starting to build it for its own.
When a Medical Billing Outsourcing Company Stops Compounding, and What to Do About It
A mid-size Indian RCM company built on coding and billing seats will keep growing for a while and then stop compounding. The moves that change the trajectory, and the checks a hospital should run before outsourcing.
Denial Management and the RCM Value Chain: Where Revenue Is Lost and Who Earns the Margin
Most claim denials are caused upstream and paid for downstream. How denial management actually works, how it differs for Indian hospitals, and why the most valuable position in the chain is the data it produces.
Five Myths About Healthcare RCM and Medical Coding in India
Most of what founders, investors and hospital managers believe about medical coding and RCM in India is a decade out of date. Here are five beliefs that cost real money.
AR Days, Clean Claim Rate and the Other RCM Numbers a Hospital CFO Should Track
Most Indian hospitals know their revenue and their bed occupancy to the decimal, and their AR days only roughly. Here are the seven revenue cycle numbers worth tracking, with formulas and rupee examples.
RCM Companies in India: Who Bought Them, Why, and What Buyers Look For
Between September 2024 and August 2026, nearly every large Indian-origin RCM company was bought by global private equity or filed to list. What the deals were, what drove them, and what buyers test for.
Healthcare BPO in India: Why US Hospitals Run Their Revenue Cycles From Here
India is one of the largest delivery bases for US hospitals' billing, coding and denial work. The industry is large, owned increasingly by global private equity, and about to be re-priced by AI.
How India's design and creative industry makes money, and where it is heading
Demand for design in India is rising while the price of design execution is falling. This report sets out the market, the economics of a studio, where AI changes the value chain, and what founders and investors should do about it.
What design consulting sells, and why one logo costs twenty times another
A logo for ₹2 lakh and a logo for ₹40 lakh are different products. Design consulting splits into four formats, and a studio that does not know which one it runs will misprice all of them.
Five ways to build a better design agency business in India
Most Indian studios have the talent for their next stage of growth. What they lack is the contract, the price and the positioning around it. Here are five places the money is sitting.
The design agency risks that close studios, and two that get too much attention
Freelance platforms and recessions get the headlines. Studios in India are more often broken by quieter things: execution revenue AI is repricing, senior talent leaving, a founder nobody can replace, and scope that keeps growing for free.
Which graphic design tasks AI takes from a studio, and which it cannot
AI is not taking design work in one sweep. It is taking the repeatable stages a studio used to bill for, one task at a time, and leaving the judgement calls more valuable than before.
Impact Reporting Never Ends: Make It an Asset
About four months after the round closes, an email arrives with a reporting template and forty fields nobody tracks. Impact measurement runs for as long as the money does, and built properly, it's one of the more useful assets a company can own.
Funding Affordable Healthcare in India
Health access attracts more patient capital in India than almost any other theme. It's also where the qualification test bites hardest, because a lot of Indian healthcare is already commercially fundable, and patient money has no business going there.
Who Actually Funds This: A Founder's Map
Five families fund impact businesses in India, each with its own calendar and behaviour. Knowing which one fits saves months of chasing the wrong door.
The Capital Stack, Cheapest to Most Commercial
Founders raise a round. Capital actually comes in layers, ordered by how much return it wants back. Each layer should buy the de-risking that makes the next one cheaper, and taking them out of order is expensive.
Story Is Not the Pitch. Evidence Is.
"I think we just need to position this better." The instinct is right and the diagnosis is usually wrong. Why evidence is load-bearing in impact capital, what positioning actually means, and the one claim no founder can narrate.
Are You an Impact Company and Don't Know It?
Founders get this wrong in both directions. Some assume doing good means they qualify; others assume a commercial business never could. There is an actual test, four gates, and most companies fail the same one.
The Same Business, Five Different Conversations
The same deck gets five different reactions from five kinds of impact capital. That isn't incoherence: each funder is asking the one question their mandate forces. Here's the grammar they share, and the five dialects they speak.
Pricing Is a Valuation Conversation, Not Just a Profitability One
Recovered price is almost pure EBITDA, and EBITDA is what gets multiplied. Why pricing discipline shows up in your valuation, not just your P&L.
Payment Terms Are Price: What a 90-Day Receivable Really Costs
Ninety-day terms cost you around 3.5% of every invoice. It's a discount your sales team gave without knowing, and nobody counts it.
Hospital Pricing: Payer Mix, Package Rates and the Money You Never Collect
A hospital's tariff is not its price. Between the bill raised and the money banked sit disallowances, package caps and payer mix. Where the margin goes.
Price Discovery: Finding Competitor Prices When Nobody Publishes Them
Indian B2B prices are almost never published, so most founders guess. Ten legitimate ways to find out what the market actually pays before you quote.
How to Raise Prices Without Losing Customers
A 10% price increase survives losing 16% of your customers; most companies lose under 3%. The seven-step sequence for getting there without the fallout.
Pricing AI Products: The Margin Moved and Nobody Repriced
If you charge per seat for software that replaces seats, your best outcome is your worst commercial result.
How to Price B2B Software in India
Approval thresholds, reverse auctions, free implementation and the India-versus-global question. What actually decides price in Indian enterprise software.
Why Your 45% Margin D2C Product Loses Money on COD
Your blended margin says the product is fine. One channel is quietly paying for another.
Your Rate Card Is Not Your Price
Your real price is your rate card multiplied by your utilisation. Most firms have never calculated the second number.
What You Charge Per: The Pricing Decision You Can't Undo
The price you set is easy to change. What you charge per is not.
GST and Pricing: B2B and B2C Need Different Price Points
The same 18% is almost invisible to a business buyer and very visible to a consumer. Price accordingly.
Good, Better, Best: Designing Tiers That Actually Work
Most tiers are built around what was easy to build. They should be built around what the customer values.
The Week Money Changed Hands
Rentomojo's IPO moved about $115 Mn between shareholders in five days. Startups raised $58.9 Mn in the same week, and only one of those numbers pays for growth.
RevenueOS for platforms and marketplaces
Every marketplace founder is very good at one side of the business, usually the side they came from. But a marketplace doesn't grow by adding supply or demand. It grows by matching them, and you can add a great deal of one side without the matching improving at all.
RevenueOS for D2C and ecommerce
A revenue operating system for D2C: plan by channel, split new customers from repeat, and judge margin at CM3, never the blended number.
What is FP&A?
FP&A stands for Financial Planning and Analysis, which is an expansion that explains nothing. The function it names is specific: deciding what the company is going to do with its money, and then holding the company to that decision. What it produces, how it differs from the accounting you already pay for, who does the work, and the honest answer on whether to build it or buy it.
The Capital Most Founders Never See
A diagnostics chain across tier-2 towns was told its margins were thin and its geography hard. In the language of a whole class of investors, it was an impact business, and there were funders whose entire job was to back exactly what it was building. Not a shortage of capital: a blind spot about which capital.
Why price level is the last decision, not the first
Nagle and Holden draw pricing as a pyramid: value creation, price structure, value communication, pricing policy, and only then price level. Most companies work it upside down, starting at the number and never touching structure or policy. For Indian startups there is a sixth thing the original model assumed you already had.
The most expensive word in Indian B2B is "complimentary"
Cut the price and five people see it. Waive the implementation and nobody notices, until it adds up to a third of the deal.
Every large corporate has a VP of Pricing. Your startup has nobody.
In most large companies somebody owns price outright: no sales quota, authority over the deal desk, and the standing to refuse a discount. Indian startups have nobody, so pricing lives in a founder's head, a salesperson's discretion and a quote template that has drifted. You cannot justify the headcount yet, but the function costs a fortnight to install.
The discount breakeven table every salesperson should carry
Most discounting arguments are arguments about a number nobody in the room has calculated. One line of arithmetic ends them: the extra volume a discount demands just to stand still. Here is the table, the give-get rule that follows from it, and the four-row matrix that governs who may spend your margin.
The pocket price waterfall: finding the 20% you never knew you gave away
There are two prices in every deal you close: the one you negotiated and the one you actually kept. The pocket price waterfall shows every step between them, and in Indian B2B about half the gap sits below the invoice line where no discount report can see it. Twenty contracts and one afternoon is the whole method.
Gross margin is the deck number. Contribution margin is the decision number.
A founder approved 25% off believing he held 75% margin. He held 47.5%, and after the discount, 30%. Gross margin answers whether this is a good business. Contribution margin answers whether to do this deal at this price, and it is the one almost nobody computes.
Pricing strategy for Indian startups and MSMEs: the ultimate guide to profitable growth and enterprise value
Recover four percent of the price you are leaking on ₹25 crore of revenue and you have added ₹1 crore to EBITDA, which at twelve times is ₹12 crore of enterprise value. The same EBITDA through growth takes a year of exceptional execution. This is the guide to the lever almost no Indian founder is pulling: the four leaks, the contribution margin floor, the four stages of a pricing practice, and the six archetypes.
RevenueOS for manufacturing
A revenue operating system for manufacturers: planning from plant capacity, demand built rather than found, and collection tracked as closely as dispatch.
RevenueOS for hospitals and diagnostics
Ask a hospital promoter how revenue is doing and you get a single number, an average of five very different businesses that each leak in a different place. The pillars of a revenue operating system don't change for healthcare; the instrumentation does. What planning, demand, execution, governance and predictability look like calibrated to beds, occupancy and ARPOB.
How mature is your revenue engine?
Most companies are strong on one or two pillars and quietly weak on the rest. The trouble is they fix the visible one. A maturity read across the five pillars of a revenue operating system, and the order in which to repair them.
RevenueOS for SaaS
Ask a SaaS founder how growth is going and you'll hear about new logos. Ask what happened to the customers they signed two years ago and the answer is much less crisp. In a subscription business, the hole in the bottom of the bucket decides the outcome.
Revenue predictability: the one thing an investor can underwrite
Every founder wants a forecast they can trust, and most go looking for it in a tool. Predictability is the fifth pillar of a revenue operating system and the only one you can't build directly: it is what the other four produce.
Revenue governance: the cadence that makes a plan real
Every company has a revenue meeting. Almost none of them have revenue governance. The difference is whether anything changes as a result: what an operating review asks, what a charter has to name, and which questions belong weekly, monthly and quarterly.
Revenue execution: from interested to closed
We have plenty of pipeline and nothing is converting: the complaint arrives in almost identical words, and the instinct that follows is always to pressure the close. It never works twice, because the deal died four steps upstream. What execution discipline looks like when stages are named after the buyer rather than the seller.
Revenue planning: a target you can actually work with
Most revenue plans are a single hopeful number on a slide. A real plan breaks into pipeline, conversion, deal length and capacity, so your team can act on it before the quarter is over.
Demand generation: pipeline is built, not found
"We need more leads" is the most common diagnosis in business, and it is usually offered with a shrug. Pipeline is not weather. Four numbers turn a revenue target into a monthly enquiry target with a date on it, and a name against it.
Fundraising rigour vs revenue rigour
The founder who can defend every assumption in a fundraising model often can't say, two months later, why last month's revenue missed. That isn't a skills gap, it's a rigour gap, and it is the most expensive one we see. Sriram Chidambaram on pointing the discipline that raised the round at the engine that makes the next round a formality.
Sales is a zero-sum game. Only the process is yours.
Raising the target doesn't change what produces the number. Sriram Chidambaram on the four inputs a founder can actually control, and why pushing harder isn't one of them.
Don't wait for the investor to find the problems. Find and fix them before the investor does.
Before a raise, an acquisition or a lender's review, ask one question: if an investor looked at our business tomorrow, what would they find? CA Mallavarjalla Mounika on pre-due diligence, the nine areas it covers, and why the goal is control, not perfection.
A term sheet is two pages. It decides the next ten years of your company.
CS Manavi Arora walks through the five clauses worth reading closely, including the information-rights clause that could have cost years to undo.
Most founders don't lose control at the negotiating table. They lose it months after they've signed.
A deal breaker is not always the clause that makes you walk away. More often it is the one nobody told you was one. CS Manavi Arora on five clauses in Indian funding rounds that quietly cost founders control.
The hardest revenue in business
In healthcare, revenue doesn't fracture, it shatters across payers. Beds and analysers earn only when running, inventory expires, and the workforce that drives the P&L goes unmeasured. Sriram Chidambaram on why the operators who master this information become the ones worth backing.
You can't AI your way out of a broken base
Every founder now asks how AI will transform their finance function. The honest answer starts with a warning: pointed at a broken base, AI doesn't fix the problem, it accelerates it. Sriram Chidambaram on the precondition that decides who gets value from AI.
One stack, many shapes
Every company runs on the same information stack, but the stream that hurts you first depends on how you make money. Sriram Chidambaram walks the archetypes (SaaS, platforms, D2C, manufacturing, deep tech) and the two streams almost everyone under-instruments.
Below ₹20 crore, you can run on gut. Above it, gut starts to lie to you.
Most finance writing is for venture-funded startups. This one is for the MSME owner who built a real business with their own money, and hits an inflection point almost no one talks about: the moment gut instinct stops being enough.
Board reporting and investor reporting are not the same thing
A board pack is a trust artifact, built to govern. Investor reporting lives or dies on whether the numbers bridge. Sriram Chidambaram on why the two must never be confused, and why they must always come from one set of numbers.
When Sovereign Money Bet On Indian Hardware
Temasek co-led Pixxel. A Government of India mission co-led QNu Labs. Between them, 38% of the week's $321.9 Mn, and a clear signal about which kind of capital is underwriting Indian deep tech.
The 5 levels of information maturity
Five rungs from reactive scramble to institutional trust, and the trap at rung two: a clean monthly pack that only looks backward, mistaken for success.
Capital Rotates To The Physical Economy
India's VCs backed atoms over bits with $176.5 Mn this week. A read on the hardware rounds that carried the total, the policy money sitting behind them, and what the rotation asks of a software founder.
Director Loan to Your Startup: Why It Might Not Be Legal
A director can lend to their own private limited company, but only with a written declaration, a board resolution and Form DPT-3. Here is what founders miss.
Why Startups Don't Fail to Scale Because of the Market. They Fail Because of the Process.
For twelve to eighteen months a founder obsesses over fundraising. Then the money lands, and almost nobody has spent a fraction of that energy designing how revenue is actually supposed to scale. Sriram Chidambaram introduces RevenueOS.
The Information Stack, explained
If the financials aren't the system, what is? The whole Information Stack framework in one place: three data streams, five layers, and the discipline that turns raw data into decisions and capital.
Investors don't fund your numbers. They fund their confidence in your numbers.
A round rarely drags because the business is weak. It drags because the numbers don't cohere, and the investor can't get comfortable enough to move. Sriram Chidambaram on capital readiness, the data room, and why the closer someone looks, the stronger your story should get.
Atoms Over Apps: The Week India's Capital Went Physical
This was the week capital moved from screens to steel. Ecommerce and advanced hardware took more than half of everything raised, and that shift changes the questions a founder should be asking about money.
The Week Capital Moved Closer To The Exit
$233.2 Mn across 19 rounds, and almost all of it late. A read on why Indian capital moved closer to the exit in the week of 17-21 August 2026, and who that leaves behind.
The Week Capital Chose Structure Over Story
Twelve rounds, four fund closes, and one very clear message. Why the week of 10-14 August 2026 rewarded companies with structure over companies with a story.
India Funded Distribution This Week, Not Product
Read the table, not the headline. In the week of 3-7 August 2026 Indian capital paid for distribution, customers already reachable, rather than for anything newly invented.
The Agent Layer Is Winning. It Does Not Own The Ground It Stands On
The application layer took the money this week. It also rents every layer beneath it. What Indian AI startups actually own, and what they are paying someone else for.
The Middle Fell Out
Seed held. The large rounds held. What thinned was everything in between. Three weeks of Indian startup funding data, and what a hollowed-out middle means for a Series A founder.
The $105 Million Week
The mega-round left. The market stayed. What $105 Mn across a quiet week says about the base of the Indian startup funding table, once the headline deal is stripped out.
The $1.1 Billion Week
From CRED's $900M raise from Meta to a new proptech unicorn, decoding where the money actually moved in the week of 21-26 June 2026, and where it didn't.
The $426 Million Week
Indian startups raised $426 Mn across 19 deals. A plain-English guide to every round in the week of 15-19 June 2026, the sectors that drew capital, and the investors behind them.
The $243 Million Week
Indian startups raised $242.6 Mn across 25 deals, up 30% on the week before. A decision-useful read on which rounds carried the total and what the spread says about conviction.
Why the Cheapest Cybersecurity Decision an Indian SME Can Make Is Also the Most Expensive
Cybersecurity is often viewed as a cost centre until the day it becomes a crisis. By then, the economics change dramatically. This article breaks down the financial reality of cyber incidents for Indian SMEs, from operational downtime and recovery expenses to regulatory exposure and customer trust, and explains why prevention remains the cheapest strategy available.
3,195 Attacks Per Week. And Most Indian Companies Are Still Running Antivirus From 2019.
The threat has industrialised. The defence has not. This is the gap that is costing Indian businesses thousands of crores every year.
Your SOC Has 10 Analysts. AI Is About to Make 7 of Them Redundant. Here Is What the Other 3 Need to Become.
AI is automating alert triage, investigation and response, and the SOC analyst's job is being redesigned around it. What the remaining roles have to become, and which skills to build before the transition accelerates.
India Processes One-Third of the World's Security Alerts. Why Does It Still Import Its Security Thinking?
India runs a large share of the world's security operations, yet imports the intelligence and frameworks behind them. Why operational scale has not become intelligence ownership, and what that leaves open for Indian companies to build.
Why Modi Asked Indians to Stop Buying Gold
India spent a record $72 billion importing gold in FY26, and in May the Prime Minister asked households to hold off for a year. What he said, what the duty hike did, and why the lasting fix is getting existing gold to move.
Can AMTZ and Hyderabad's Medical Devices Park Make India a Medtech Maker?
India imports most of the medical devices its hospitals use. Two state-built clusters in Visakhapatnam and Hyderabad are trying to change that, with very different results so far.
From Checkups to Continuous Care: What Wearable Medical Devices Change
Medicine has run on snapshots: a ten-minute consultation, months apart. Wearable sensors replace the snapshot with a stream. The evidence is now strong in diabetes and heart rhythm, and the business model is a subscription.
Can Medical Equipment Think? What AI in Medical Devices Really Does
More than 1,200 AI-enabled devices are cleared in the US, most of them reading scans. The evidence is strong for narrow tasks and much weaker for the bigger claims. Here is how to tell the difference.
The Hidden Profit Engine of the Medical Equipment Industry
The scanner wins the tender. The cartridges, service contracts and software licences that follow it earn the money, often for a decade. Here is how recurring revenue works in medical equipment, and what it means in India.
Medical Tourism Could Be India's Most Underrated Dollar-Revenue Business
Foreign patients pay full price, often in advance and in hard currency, and they earn hospitals about 30% more per bed. India still treats medical tourism as a side business.
Why Most of India's New Hospital Beds Are Expansions, Not New Builds
India's hospital chains are adding tens of thousands of beds, and a large part of them are going into buildings that already exist. Here is why, what the real share is, and when a new build still makes sense.
Why Most Indian Hospitals Never Scale Past One Location
India has thousands of successful single hospitals and only a handful of chains. The traits that make the first hospital work are usually the ones that stop the second.
Why AI Is Creating the Biggest Semiconductor Boom in History
A handful of AI accelerators now earn about half the industry's revenue. Here is where that money lands along the semiconductor supply chain, and why the memory cycle is the part to watch.
The Real Economics of Running a Hospital in India
A hospital is a capital project that happens to treat patients. Three numbers, capex per bed, revenue per occupied bed and occupancy, decide whether it ever pays back.
India's Semiconductor Opportunity: Can India Become a Global Chip Hub?
India now packages chips commercially and designs some of the world's most advanced ones. Whether it becomes a chip hub depends on the layers it does not yet own.
The $187 Million Week
Indian startups raised $187.4 Mn across 21 deals, up 260% week on week. A read on which rounds carried the total, and why a spike this size is usually one deal rather than a trend.
A Quiet Week, A Clear Signal
A slow week is not an empty one. What the funding of 25-29 May 2026 reveals about the barbell shape of Indian startup capital, and the seed-stage compression underneath it.
How India’s RDIF Is Shaping the Deeptech Economy: Insights From This Week’s Funding Trends
India's Research, Development and Innovation Fund (RDIF) is becoming a catalyst for deep tech. What this week's funding says about where strategic capital is going, and what the fund reveals about India's longer-term ambitions.
Venture Debt Grew 9X Faster Than VC
One round carried the week, but the more interesting number was underneath it: venture debt is growing nine times faster than venture capital, and the weekly tally never counts it.
Pricing Labs: Testing Without Breaking Sales
Founders know pricing matters. The hard part is that pricing is one of the few business decisions where you cannot easily test, because every test affects real customers, real revenue, and real deals.
Commercial DD: Testing the Business Model Under Scrutiny
When founders prepare for due diligence, most of the focus goes into financial DD. This is necessary work, and it is also incomplete. Financial DD tests what the company has been. Commercial DD tests what the company is.
Why Investors Lose Confidence Mid-Process
The most expensive moment in a fundraise is rarely the rejection at the end. It is the quiet moment, somewhere in the middle of due diligence, when an investor's confidence starts to slip.
Secretarial Discipline as Business Infrastructure
There is a quiet category of work in growing companies that nobody wants to own but everyone depends on. The secretarial layer. In most companies, it gets pushed to whoever has the least senior role on the finance or legal side.
Org Design Should Follow Strategy, Not Titles
There is a quiet moment in many growing companies when the org chart starts taking on a life of its own. The structure of the company drifts away from the strategy. This drift is invisible until the company tries to do something hard.
Integrating Accounting, MIS, and Planning Tools
In most growing companies, the finance stack tells the story of how the company grew. Three competent systems, three different versions of the truth, and a finance team that spends most of its time reconciling between them instead of using them.
Pricing Is a Strategic Lever
Most founders think about pricing the way they think about cost. A number to set, occasionally revisit, and otherwise leave alone. This is one of the cheapest mistakes a growing company can make.
Unit Economics Is Strategy, Not Finance
Most founders, when they think about unit economics, file the concept under finance. This is the cheapest way to misunderstand unit economics, and it costs companies their futures.
Revenue Recognition Mistakes That Distort Reality
Revenue is the most-watched number in a growing company. And in most growing companies, it is slightly wrong. Not wrong in a fraud sense. Wrong in a controllership sense.
Why Finance Tech Decisions Break Scaling Companies
At Series A, your finance stack works. By Series B, it stops working. The cost of the choices made at Series A starts showing up everywhere.
Why Hiring Faster Doesn't Mean Scaling Better
Most founders learn to treat hiring velocity as a proxy for growth. The logic feels intuitive. It is one of the most expensive habits a growing company can develop.
Why Growing Companies Lose Trust in Their Own Numbers
At some point in nearly every growing company, a quiet shift happens. The founder stops fully trusting the numbers. It rarely arrives as a single event. It builds up.
Fundraises Don't Fail in DD: They Fail Before It
When a fundraise stalls in diligence, founders almost always describe it as a diligence problem. The truth is that fundraises rarely fail in diligence. They fail before.
What Due Diligence Actually Evaluates (Beyond the Data Room)
When founders prepare for diligence, most of the work goes into the data room. And then diligence begins, and the founder is surprised by what gets asked.
Why Compliance Is a Capital Issue, Not a Legal One
Most founders treat compliance as paperwork. A filing here. A board resolution there. To an institutional investor, compliance is something entirely different.
DD Is Not the First Time You Should Look at Your Business
Most founders look closely at their own company twice. Once at the start. Once when serious capital is being raised. The silent gap between is what breaks fundraises.
Why Most Startups Don't Actually Have a Strategy
Ask ten founders what their strategy is, and you will hear ten different things. A pitch deck slide. A vision statement. A revenue target. None of these is strategy.
DD Is Not a Documentation Exercise
When founders prepare for diligence, almost all the work goes into the data room. And then diligence begins, and founders discover they prepared for the wrong evaluation.
Why Most Startups Don't Actually Do FP&A
Most startups think they do FP&A. They have a budget, a forecast, a monthly review. But what most startups actually have is bookkeeping with a forecast bolted on.
Why Strategy Labs Exist?
Most strategy decks die in drawers. A consulting firm spends six weeks producing a 60-page document. Two months later, the company operates exactly the way it did before.
Vision Statements Don't Drive Outcomes
Every company has a vision statement. It sits on the website. It opens the all-hands. And then the company goes back to operating the way it always did.
Recruitment Is Not HR Strategy
When growing companies talk about HR, the conversation almost always centers on hiring. Roles open. Candidates in pipeline. This is recruitment. It is not HR strategy.
Accounting Is Not Controllership
Most founders, when asked who owns the integrity of their numbers, point to their accountant. This is reasonable. It is also the source of a predictable failure mode.
Buying Tools Is Not Building a Finance Stack
At some point, the finance team starts buying tools. Accounting platform upgraded. Billing tool added. Planning tool evaluated. The software bill grows. The stack doesn't.
Workshops Don't Change Companies
The strategy workshop is a familiar ritual. Two days, sticky notes, working dinner, slides. A month later, the company is operating almost exactly as before.
Budgeting Is Not FP&A
Most founders, when asked whether they do FP&A, point to their budget. There is a spreadsheet. There is variance reporting. This is budgeting. It is not FP&A.
Filing On Time Doesn't Mean You're Compliant
Most founders point to their filings when asked about compliance. Returns done. ROC filings current. This is bureaucratic compliance. It is not what investors evaluate.
A Founder's Field Guide: How VCs Decide to Take a First Meeting
Most first meetings are decided before the deck is opened. The signals VCs actually screen for, and what a founder can do about each of them.
How Can Startups Raise Institutional Funds Successfully?
Learn how startups can raise institutional funding by building strong fundamentals, traction, financial clarity, and investor readiness. A simple guide for early-stage founders.
Skyroot's $1.1Bn Mark, Pre-Orbit
A $60M Series C valued Skyroot at $1.1Bn before it reached orbit. A specialist read on how the round was structured, who carries which risk, and what the week's other ten deals looked like beside it.